PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Infection Prevention and Control Unit (E.G.L., C.C., G.R.-Y.), the Biostatistics and Biomathematics Unit, Gertner Institute of Epidemiology and Health Policy Research (R.F., A.Z., C.R., L.F.), the Automated Mega-Laboratory, Laboratory Division (R.D., K.A.), the Department of Clinical Microbiology (S.A.), and the Sheba Medical Center Management (Y.K.), Sheba Medical Center Tel Hashomer, and the Central Virology Laboratory, Public Health Services, Ministry of Health (Y.L., V.I., E.M.), Ramat Gan, and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (E.G.L., Y.L., E.M., Y.K., G.R.-Y.) - all in Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1056/NEJMoa2114583
?:hasPublicationType
?:journal
  • The New England journal of medicine
is ?:pmid of
?:pmid
?:pmid
  • 34614326
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all